# Eucrates Biomedical Acquisition Corp. (EUCR)

Source: https://www.quantisnow.com/company/EUCR
Generated: 2026-11-17T14:38:59.549Z

- Ticker: EUCR
- Exchange: NASDAQ
- Sector: Finance
- Industry: Blank Checks
- IPO year: 2020

## About

Eucrates Biomedical Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.

## Latest EUCR news and filings

- 2023-05-08 10:03 UTC [SEC Form 15-12G filed by Eucrates Biomedical Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-15-12g-filed-by-eucrates-biomedical-acquisition-corp-4458476)
- 2023-04-26 20:52 UTC [SEC Form 25-NSE filed by Eucrates Biomedical Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-25-nse-filed-by-eucrates-biomedical-acquisition-corp-4391491)
- 2023-04-13 20:50 UTC [SEC Form 10-K] [SEC Form 10-K filed by Eucrates Biomedical Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-10-k-filed-by-eucrates-biomedical-acquisition-corp-4334017)
- 2023-04-12 04:59 UTC [Market Insight] [Reported Late Tuesday April 11, Eucrates Biomedical Acquisition Corp. Announces Liquidation; Co To Redeem All Outstanding Shares At A Per-Share Redemption Price Of ~$10](https://www.quantisnow.com/insight/reported-late-tuesday-april-11-eucrates-biomedical-acquisition-corp-announces-4323950)
- 2023-04-11 21:00 UTC [SEC Form 8-K] [Eucrates Biomedical Acquisition Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/eucrates-biomedical-acquisition-corp-filed-sec-form-8-k-other-events-4323380)
- 2023-04-11 21:00 UTC [Public Offering] [Eucrates Biomedical Acquisition Corp. Announces Liquidation](https://www.quantisnow.com/insight/eucrates-biomedical-acquisition-corp-announces-liquidation-4323359)
- 2023-04-03 20:15 UTC [SEC Form 8-K] [Eucrates Biomedical Acquisition Corp. filed SEC Form 8-K: Creation of a Direct Financial Obligation](https://www.quantisnow.com/insight/eucrates-biomedical-acquisition-corp-filed-sec-form-8-k-creation-of-4289374)
- 2023-03-29 20:40 UTC [SEC Form NT 10-K filed by Eucrates Biomedical Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-nt-10-k-filed-by-eucrates-biomedical-acquisition-corp-4267078)
- 2023-02-16 21:13 UTC [SEC Form 8-K] [Eucrates Biomedical Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Financial Statements and Exhibits](https://www.quantisnow.com/insight/eucrates-biomedical-acquisition-corp-filed-sec-form-8-k-entry-into-4078755)
- 2023-02-10 14:43 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Eucrates Biomedical Acquisition Corp. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-eucrates-biomedical-acquisition-corp-4038098)
- 2022-11-14 22:03 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Eucrates Biomedical Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-eucrates-biomedical-acquisition-corp-3684116)
- 2022-11-09 21:43 UTC [SEC Schedule 13G] [SEC Form SC 13G filed by Eucrates Biomedical Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-sc-13g-filed-by-eucrates-biomedical-acquisition-corp-3659504)
- 2022-11-08 21:27 UTC [SEC Form 8-K] [Eucrates Biomedical Acquisition Corp. filed SEC Form 8-K: Creation of a Direct Financial Obligation](https://www.quantisnow.com/insight/eucrates-biomedical-acquisition-corp-filed-sec-form-8-k-creation-of-3651424)
- 2022-10-31 20:19 UTC [SEC Form 8-K] [Eucrates Biomedical Acquisition Corp. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits](https://www.quantisnow.com/insight/eucrates-biomedical-acquisition-corp-filed-sec-form-8-k-amendments-to-3603700)
- 2022-10-24 20:39 UTC [SEC Form 8-K] [Eucrates Biomedical Acquisition Corp. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure](https://www.quantisnow.com/insight/eucrates-biomedical-acquisition-corp-filed-sec-form-8-k-submission-of-3568976)
- 2022-10-12 20:41 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by Eucrates Biomedical Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-eucrates-biomedical-acquisition-corp-3525179)
- 2022-10-05 21:21 UTC [SEC Form PRER14A filed by Eucrates Biomedical Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-prer14a-filed-by-eucrates-biomedical-acquisition-corp-3499769)
- 2022-09-28 21:26 UTC [SEC Form PRE 14A] [SEC Form PRE 14A filed by Eucrates Biomedical Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-pre-14a-filed-by-eucrates-biomedical-acquisition-corp-3468203)
- 2022-08-15 21:08 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Eucrates Biomedical Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-eucrates-biomedical-acquisition-corp-3289592)
- 2022-05-23 20:31 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Eucrates Biomedical Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-eucrates-biomedical-acquisition-corp-2930249)
- 2022-05-16 20:31 UTC [SEC Form NT 10-Q filed by Eucrates Biomedical Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-nt-10-q-filed-by-eucrates-biomedical-acquisition-corp-2896687)
- 2022-04-09 00:32 UTC [SEC Form 10-K] [SEC Form 10-K filed by Eucrates Biomedical Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-10-k-filed-by-eucrates-biomedical-acquisition-corp-2701815)
- 2022-03-31 21:08 UTC [SEC Form NT 10-K filed by Eucrates Biomedical Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-nt-10-k-filed-by-eucrates-biomedical-acquisition-corp-2660435)
- 2022-02-14 19:34 UTC [SEC Schedule 13G] [SEC Form SC 13G filed by Eucrates Biomedical Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-sc-13g-filed-by-eucrates-biomedical-acquisition-corp-2410868)
- 2022-02-08 22:12 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Eucrates Biomedical Acquisition Corp. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-eucrates-biomedical-acquisition-corp-2374849)
- 2022-01-26 21:15 UTC [SEC Form 8-K] [Eucrates Biomedical Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Financial Statements and Exhibits](https://www.quantisnow.com/insight/eucrates-biomedical-acquisition-corp-filed-sec-form-8-k-entry-into-2306015)
- 2021-12-20 21:33 UTC [SEC Form 10-K] [SEC Form 10-K/A filed by Eucrates Biomedical Acquisition Corp. (Amendment)](https://www.quantisnow.com/insight/sec-form-10-ka-filed-by-eucrates-biomedical-acquisition-corp-amendment-2165890)
- 2021-11-22 21:32 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Eucrates Biomedical Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-eucrates-biomedical-acquisition-corp-2042894)
- 2021-11-19 22:20 UTC [SEC Form 8-K] [Eucrates Biomedical Acquisition Corp. filed SEC Form 8-K: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review](https://www.quantisnow.com/insight/eucrates-biomedical-acquisition-corp-filed-sec-form-8-k-non-reliance-on-2037098)
- 2021-08-16 19:26 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Eucrates Biomedical Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-eucrates-biomedical-acquisition-corp-1673527)
- 2021-07-16 20:06 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Eucrates Biomedical Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-eucrates-biomedical-acquisition-corp-1399022)
- 2021-07-15 21:28 UTC [SEC Form 10-K] [SEC Form 10-K/A filed by Eucrates Biomedical Acquisition Corp. (Amendment)](https://www.quantisnow.com/insight/sec-form-10-ka-filed-by-eucrates-biomedical-acquisition-corp-amendment-1386957)
- 2021-06-21 20:22 UTC [SEC Form 8-K] [Eucrates Biomedical Acquisition Corp. filed SEC Form 8-K: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review](https://www.quantisnow.com/insight/eucrates-biomedical-acquisition-corp-filed-sec-form-8-k-non-reliance-on-1089597)
- 2021-06-01 12:05 UTC [SEC Form 8-K] [Eucrates Biomedical Acquisition Corp. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/eucrates-biomedical-acquisition-corp-filed-sec-form-8-k-notice-of-915272)
- 2021-06-01 12:00 UTC [Public Offering] [Eucrates Biomedical Acquisition Corp. Receives Expected Notice From Nasdaq Regarding Delayed Quarterly Report](https://www.quantisnow.com/insight/eucrates-biomedical-acquisition-corp-receives-expected-notice-from-nasdaq-regarding-914937)
- 2021-05-17 11:32 UTC [SEC Form NT 10-Q filed by Eucrates Biomedical Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-nt-10-q-filed-by-eucrates-biomedical-acquisition-corp-747819)
- 2021-03-31 20:01 UTC [SEC Form 10-K] [SEC Form 10-K filed by Eucrates Biomedical Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-10-k-filed-by-eucrates-biomedical-acquisition-corp-573022)
- 2021-02-12 21:02 UTC [SEC Schedule 13G] [SEC Form SC 13G filed](https://www.quantisnow.com/insight/sec-form-sc-13g-filed-390693)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/EUCR
- Earnings history: https://www.quantisnow.com/earnings/EUCR
- Dividend history: https://www.quantisnow.com/dividends/EUCR
- Insider transactions: https://www.quantisnow.com/insiders/EUCR
- Options chain: https://www.quantisnow.com/options/EUCR
- SEC 8-K filings only: https://www.quantisnow.com/company/EUCR/8-k
- RSS and alerts for EUCR: https://www.quantisnow.com/docs/rss-feeds.md
